Evidence map›Paper›PMID 26696322›Full record

ArticleAging cell2016

CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study.

Ioakim Spyridopoulos, Carmen Martin-Ruiz, Catharien Hilkens, Mohammad E Yadegarfar, John Isaacs, Carol Jagger, Tom Kirkwood, Thomas von Zglinicki

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 3 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 3 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Acyclic graphs to define models of relationships between human cytomegalovirus, cardiovascular disease and all-cause mortality in UK Biobank.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. T-Cell Senescence in Human Metabolic Diseases.Diabetes & metabolism journal · 2024
    Review
  19. Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ioakim SpyridopoulosNewcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Carmen Martin-RuizNewcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Catharien HilkensInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Mohammad E YadegarfarNewcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
John IsaacsNewcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Carol JaggerNewcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Tom KirkwoodNewcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Thomas von ZglinickiNewcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Newcastle University · GB

Funding

British Heart Foundation FS/12/31/29533British Heart Foundation FS/15/77/31823British Heart Foundation PG/11/117/29290British Heart Foundation PG/12/47/29681British Heart Foundation PG/15/4/31178Medical Research Council G0500997Medical Research Council G0601333Medical Research Council MR/J50001X/1
6 · The paper itself

Abstract

Although chronic infection with cytomegalovirus (CMV) is known to drive T lymphocytes toward a senescent phenotype, it remains controversial whether and how CMV can cause coronary heart disease (CHD). To explore whether CMV seropositivity or T-cell populations associated with immunosenescence were informative for adverse cardiovascular outcome in the very old, we prospectively analyzed peripheral blood samples from 751 octogenarians (38% males) from the Newcastle 85+ study for their power to predict survival during a 65-month follow-up (47.3% survival rate). CMV-seropositive participants showed a higher prevalence of CHD (37.7% vs. 26.7%, P = 0.030) compared to CMV-seronegative participants together with lower CD4/CD8 ratio (1.7 vs. 4.1, P < 0.0001) and higher frequencies of senescence-like CD4 memory cells (41.1% vs. 4.5%, P < 0.001) and senescence-like CD8 memory cells (TEMRA, 28.1% vs. 6.7%, P < 0.001). CMV seropositivity was also associated with increased six-year cardiovascular mortality (HR 1.75 [1.09-2.82], P = 0.021) or death from myocardial infarction and stroke (HR 1.89 [107-3.36], P = 0.029). Gender-adjusted multivariate Cox regression analysis revealed that low percentages of senescence-like CD4 T cells (HR 0.48 [0.32-0.72], P < 0.001) and near-senescent (CD27 negative) CD8 T cells (HR 0.60 [0.41-0.88], P = 0.029) reduced the risk of cardiovascular death. For senescence-like CD4, but not near-senescent CD8 T cells, these associations remained robust after additional adjustment for CMV status, comorbidities, and inflammation markers. We conclude that CMV seropositivity is linked to a higher incidence of CHD in octogenarians and that senescence in both the CD4 and CD8 T-cell compartments is a predictor of overall cardiovascular mortality as well as death from myocardial infarction and stroke.

Indexed as

Aged, 80 and overAge FactorsCardiovascular DiseasesChronic DiseaseCytomegalovirus InfectionsFemaleHumansMaleT-LymphocytesUnited KingdomagingCD4CD8coronary heart diseasecytomegalovirusimmunosenescenceoctogenarianssurvivalT lymphocytes

Identifiers

PMID26696322
PMCPMC4783336
OpenAlexW2214000744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.